• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HUMASIS CO., LTD. CELLTRION DIATRUST COVID-19 AG RAPID TEST; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HUMASIS CO., LTD. CELLTRION DIATRUST COVID-19 AG RAPID TEST; IN VITRO DIAGNOSTICS Back to Search Results
Lot Number COVGCB1003
Device Problem Display Difficult to Read (1181)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Event Description
The initial reporter in health care service center reported product complaints from his/her experiences with the celltrion diatrust covid-19 ag rapid test on (b)(6) 2022 via email.The issue is with the lot # covgcb1003 exp date: 11/4/2022.It was said the positive control is almost too faint to read or does not show up and it was reported from several of their clinics on this lot number that he/she has received in the last few days.The reporter said he/she has other reports that the lines are very faint and it is taking 13-15 minutes for the positive line to appear.The reporter asked us to check if this is an issue with this lot number.The reporter said he/she has also contacted his/her distributor with this issue and this is the first time the reporter have had this issue reported to him/her and he/she have used this test for several months.Importer comment: importer responded to reporter that due to reading test before 15 minutes or after 20 minutes, sometimes false positive or negative result identified and acknowledged this complaint is about having faint line or missing line in positive control.We also asked more details to the reporter such as affected quantity, number of customers(or clinics), name of distributor etc and received the information that he/she have had two different clinics that had issues with this lot number and the positive control (at least 2 boxes) it is the first time we receive this type of complaints regarding the batch # covgcb1003.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLTRION DIATRUST COVID-19 AG RAPID TEST
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
HUMASIS CO., LTD.
88, jeonpa-ro
dongan-gu
anyang-si, gyeonggi-do 14042
KS  14042
MDR Report Key13906042
MDR Text Key295251772
Report Number3008719759-2022-00057
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/04/2022
Device Lot NumberCOVGCB1003
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/02/2022
Event Location Other
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/25/2022
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-